Digital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the...

Area of Science:

• Pain Management
• Artificial Intelligence in Medicine
• Digital Health

Background:

• Opioids are crucial for chronic pain but have high risks of misuse, morbidity, and mortality.
• Tolerance to opioids complicates dosing and increases the need for side effect management.
• First-generation digital systems for analgesics showed limited clinical efficacy and adoption.

Purpose of the Study:

• To present a novel digital analgesic system controlled by a second-generation artificial intelligence (AI) algorithm.
• To enhance opioid therapeutic regimens by focusing on improved patient outcomes and reduced side effects.
• To demonstrate the personalized regulation of analgesic administration for individual patient needs.

Main Methods:

• Development and implementation of a second-generation AI system to control analgesic administration.
• Personalized regulation of medication delivery based on individual clinical response.
• Focus on optimizing patient outcomes, including clinical response and minimizing adverse events.

Main Results:

• The digital analgesic system enables personalized, AI-regulated administration of analgesics.
• Demonstrated potential for dose optimization, leading to improved effectiveness.
• Showcased significant reduction in opioid-related side effects and improved adherence to therapeutic regimens.

Conclusions:

• Second-generation AI systems offer enhanced patient outcomes in pain management.
• The digital analgesic system improves clinician experience and chronic pain management.
• This AI-driven approach reduces healthcare costs associated with opioid-related morbidity and presents a market disruption.